1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e "Arthritis & Rheumatism")
Direct Link:
1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Research Article
You have full text access to this OnlineOpen article
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
Article first published online: 8 DEC 2004
DOI: 10.1002/art.20666
Copyright © 2004 by the American College of Rheumatology
Additional Information
How to Cite
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., Galeazzi, M., Gül, A., Levy, Y., Petera, P., Popovic, R., Petrovic, R., Sinico, R. A., Cattaneo, R., Font, J., Depresseux, G., Cosyns, J.-P. and Cervera, R. (2004), Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis & Rheumatism, 50: 3934–3940. doi: 10.1002/art.20666
Publication History
- Issue published online: 8 DEC 2004
- Article first published online: 8 DEC 2004
- Manuscript Accepted: 23 AUG 2004
- Manuscript Received: 10 MAR 2004
Funded by
- European League Against Rheumatism
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , , , , , , , , , , , American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis, Arthritis Care & Research, 2012, 64, 6
- 2, Atteinte rénale du lupus érythémateux disséminé, La Presse Médicale, 2012, 41, 3, 260
- 3, , , , , , , , , , Diagnóstico y tratamiento de la nefritis lúpica, Revista ClÃnica Española, 2012, 212, 3, 147.e1
- 4
- 5
- 6, , , , , , , Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis, Clinical and Experimental Nephrology, 2012,
- 7, , Pulse cyclophosphamide induction treatment in Thai children with diffuse proliferative lupus nephritis, Nephrology, 2012, 17, 3Direct Link:
- 8
- 9, Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients, Arthritis Research & Therapy, 2012, 14, 1, 202
- 10, , , Treatment of Proliferative and Membranous Lupus Nephritis, The American Journal of the Medical Sciences, 2012, 343, 1, 86
- 11, , , , , , , Anti-C1q and anti-dsDNA antibodies in systemic lupus erythematosus: Relationship with disease activity and renal involvement in Sharkia governorate, Egypt, The Egyptian Rheumatologist, 2011, 33, 4, 203
- 12, , Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuria, Nephrology Dialysis Transplantation, 2011,
- 13
- 14, , Molecular evaluation of renal biopsies: a search for predictive and prognostic markers in lupus nephritis, Expert Review of Molecular Diagnostics, 2011, 11, 6, 561
- 15, , , Pediatric SLE—towards a comprehensive management plan, Nature Reviews Rheumatology, 2011, 7, 4, 225
- 16, , , , , Predictive value of remission status after 6Â months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis, Clinical Rheumatology, 2011, 30, 11, 1399
- 17, , , , , , , Strategy for second kidney biopsy in patients with lupus nephritis, Nephrology Dialysis Transplantation, 2011, 27, 4, 1472
- 18
- 19
- 20
- 21
- 22
- 23, , , , Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease, Pediatric Clinics of North America, 2010, 57, 1, 239
- 24, , , , , Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases, Nephrology Dialysis Transplantation, 2010, 25, 12, 3939
- 25
- 26, , , , , , , , , , , , Outcomes in Biopsy-Proven Lupus Nephritis, Medicine, 2010, 89, 5, 300
- 27
- 28, , Treatment of proliferative lupus nephritis: a slowly changing landscape, Nature Reviews Nephrology, 2010, 7, 2, 96
- 29
- 30, , , A perspective on B-cell-targeting therapy for SLE, Modern Rheumatology, 2009, 20, 1, 1
- 31, , , Clinical approach to lupus nephritis: Recent advances, European Journal of Internal Medicine, 2009, 20, 5, 447
- 32, , , Development and testing of a decision board to help clinicians present treatment options to lupus nephritis patients in Brazil, Arthritis Care & Research, 2009, 61, 1Direct Link:
- 33, , , , , , , , , , Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study, Rheumatology, 2009, 49, 1, 128
- 34, Management of lupus nephritis—current perspectives, Indian Journal of Rheumatology, 2009, 4, 4, 153
- 35, , , , , , , , Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration, American Journal of Kidney Diseases, 2009, 54, 2, 205
- 36, , , What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?, Current Opinion in Rheumatology, 2009, 21, 3, 256
- 37, , , , What’s new in clinical trials in lupus?, International Journal of Clinical Rheumatology, 2009, 4, 4, 473
- 38
- 39
- 40
- 41, , , , , , , , , , , , Biomarkers of lupus nephritis determined by serial urine proteomics, Kidney International, 2008, 74, 6, 799
- 42, Die Nierenbeteiligung beim systemischen Lupus erythematodes, Der Nephrologe, 2008, 3, 6, 471
- 43, , Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus, Expert Opinion on Drug Safety, 2008, 7, 4, 411
- 44, Is individualized therapy the future of lupus treatment?, Future Rheumatology, 2008, 3, 2, 143
- 45, , , , , , , Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen, Pediatric Nephrology, 2008, 23, 10, 1877
- 46, , Mycophenolate mofetil for lupus nephritis, Expert Review of Clinical Immunology, 2008, 4, 3, 313
- 47, , , , Pharmacotherapy of lupus nephritis: time for a consensus?, Expert Opinion on Pharmacotherapy, 2008, 9, 12, 2099
- 48, Traitement des glomérulonéphrites lupiques prolifératives. Évolution des idées et situation en 2008, La Revue de Médecine Interne, 2008, 29, 9, 710
- 49, , , , , Tratamiento de inducción en la nefritis lúpica tipo IV, Seminarios de la Fundación Española de ReumatologÃa, 2008, 9, 2, 105
- 50
- 51, , , Treatment of Lupus Nephritis, ReumatologÃa ClÃnica (English Edition), 2008, 4, 4, 140
- 52, , Update on the management of lupus nephritis: let the treatment fit the patient, Nature Clinical Practice Rheumatology, 2008, 4, 9, 464
- 53
- 54
- 55, , Future prospects in the treatment of lupus nephritis: proliferative lupus nephritis, Future Rheumatology, 2007, 2, 3, 297
- 56, Histologic deterioration and more flares: The case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis, Arthritis & Rheumatism, 2007, 56, 3Direct Link:
- 57, Management of systemic lupus erythematosus in Chinese patients, Expert Review of Clinical Immunology, 2007, 3, 6, 925
- 58
- 59
- 60, , Nuevos conceptos en el tratamiento de la nefropatÃa lúpica, Revista ClÃnica Española, 2007, 207, 11, 570
- 61, , , Prognostic Value of Renal Hemodynamic Characteristics in Patients with Proliferative Lupus Nephritis, Kidney and Blood Pressure Research, 2007, 30, 3, 175
- 62, , Systemic lupus erythematosus: modern strategies for management – a moving target, Best Practice & Research Clinical Rheumatology, 2007, 21, 6, 971
- 63
- 64, , , Treatment of Proliferative Lupus Nephritis—A Critical Approach, Seminars in Arthritis and Rheumatism, 2007, 36, 4, 224
- 65, , , , , , , , , , , Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis, Arthritis & Rheumatism, 2007, 56, 3Direct Link:
- 66, , , , , , , , , , , , Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial, Kidney International, 2006, 70, 4, 732
- 67, , , , , , , , , Clinical outcomes of childhood lupus nephritis: a single center’s experience, Pediatric Nephrology, 2006, 22, 2, 222
- 68, Emerging drug therapies for systemic lupus erythematosus, Expert Opinion on Emerging Drugs, 2006, 11, 4, 597
- 69, , , European Working Party on Systemic Lupus Erythematosus: A 15-year report, Autoimmunity Reviews, 2006, 5, 8, 549
- 70, Hematopoietic stem cell transplantation in autoimmune diseases: Is the glass half full or half empty?, Arthritis & Rheumatism, 2006, 54, 12Direct Link:
- 71, , , , , , , , , , , Hepatocyte growth factor and transforming growth factor β1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis, Arthritis & Rheumatism, 2006, 54, 11Direct Link:
- 72, , Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide, Nature Clinical Practice Nephrology, 2006, 2, 6, 314
- 73, , , , , Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet’s disease, Clinical Rheumatology, 2006, 26, 8, 1365
- 74
- 75Mycophenolate Mofetil or Intravenous Cyclophosphamide in Lupus Nephritis, New England Journal of Medicine, 2006, 354, 7, 764
- 76, , Newer Therapeutic Approaches for Systemic Lupus Erythematosus: Immunosuppressive Agents, Rheumatic Disease Clinics of North America, 2006, 32, 1, 91
- 77, , Pathogenesis and treatment of systemic lupus erythematosus nephritis, Current Opinion in Internal Medicine, 2006, 5, 6, 631
- 78, Therapeutic Options for Resistant Lupus Nephritis, Seminars in Arthritis and Rheumatism, 2006, 36, 2, 71
- 79, , , Tratamiento inmunosupresor en pacientes con glomerulonefritis lúpica. Revisión de eventos adversos, ReumatologÃa ClÃnica, 2006, 2, 6, 313
- You have free access to this content80, Update on the current therapies of lupus nephritis, APLAR Journal of Rheumatology, 2006, 9, 4Direct Link:
- 81, , Blood stem cells as therapy for severe lupus, Expert Opinion on Biological Therapy, 2005, 5, 9, 1153
- 82, Can survival of systemic lupus erythematosus be further improved?, APLAR Journal of Rheumatology, 2005, 8, 3Direct Link:
- 83, , , Defining the Role of Mycophenolate Mofetil in the Treatment of Proliferative Lupus Nephritis, Drugs, 2005, 65, 17, 2429
- 84, , Diagnosis and treatment of kidney disease, Best Practice & Research Clinical Rheumatology, 2005, 19, 5, 785
- 85
- 86, , , , , , , , , , , Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis, New England Journal of Medicine, 2005, 353, 21, 2219
- 87, , , Novel approaches to therapy for systemic lupus erythematosus: update 2005, Expert Review of Clinical Immunology, 2005, 1, 2, 223
- 88, , , Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?, Nature Clinical Practice Rheumatology, 2005, 1, 1, 22
- 89, , The role of immune ablation and stem cell transplantation in severe SLE, Best Practice & Research Clinical Rheumatology, 2005, 19, 5, 839
- 90, , , Treatment for lupus nephritis: A revisit, Nephrology, 2005, 10, 2Direct Link:
- 91, Cyclophosphamide for severe lupus nephritis: Where are we now?, Arthritis & Rheumatism, 2004, 50, 12Direct Link: